Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXV1AT
|
||||
| Drug Name |
N-{(S)-1-[2-(4-Cyclopentylmethoxy-phenylamino)-ethylcarbamoyl]-3-methyl-butyl}-4-methoxy-benzamide
|
||||
| Synonyms |
CHEMBL294260
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C28H39N3O4
|
||||
| Canonical SMILES |
COc1ccc(cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCCNc2ccc(OCC3CCCC3)cc2
|
||||
| InChI |
InChI=1S/C28H39N3O4/c1-20(2)18-26(31-27(32)22-8-12-24(34-3)13-9-22)28(33)30-17-16-29-23-10-14-25(15-11-23)35-19-21-6-4-5-7-21/h8-15,20-21,26,29H,4-7,16-19H2,1-3H3,(H,30,33)(H,31,32)/t26-/m0/s1
|
||||
| InChIKey |
YIEQKSSVMDZCNO-SANMLTNESA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.